2018 Yearbook of Neurorestoratology

Hampel, 2019, Revisiting the cholinergic hypothesis in Alzheimer’s disease: Emerging evidence from translational and clinical research, J Prev Alzheimers Dis, 6, 2 Cope, 2018, Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy, Brain, 141, 550, 10.1093/brain/awx347 Musi, 2018, Tau protein aggregation is associated with cellular senescence in the brain, Aging Cell, 17, 10.1111/acel.12840 Wei, 2018, Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer’s disease, Cell Death Dis, 9, 820, 10.1038/s41419-018-0886-1 Gatt, 2017, Importance of proactive treatment of depression in Lewy body dementias: The impact on hippocampal neurogenesis and cognition in a post-mortem study, Dement Geriatr Cogn Disord, 44, 283, 10.1159/000484437 Hu, 2018, Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson’s disease, J Biol Regul Homeost Agents, 32, 687 Pardiñas, 2018, Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, Nat Genet, 50, 381, 10.1038/s41588-018-0059-2 Shi, 2018, Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons, Nat Med, 24, 313, 10.1038/nm.4490 Sorrells, 2018, Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults, Nature, 555, 377, 10.1038/nature25975 Boldrini, 2018, Human hippocampal neurogenesis persists throughout aging, Cell Stem Cell, 22, 589, 10.1016/j.stem.2018.03.015 Nijboer, 2018, Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage, Stem Cells Dev, 27, 313, 10.1089/scd.2017.0148 Kunath, 2018, Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?, Eur J Neurosci, 49, 453, 10.1111/ejn.14314 da Silva, 2018, Dopamine neuron activity before action initiation gates and invigorates future movements, Nature, 554, 244, 10.1038/nature25457 Liu, 2018, Dopamine secretion is mediated by sparse active zone-like release sites, Cell, 172, 706, 10.1016/j.cell.2018.01.008 Konermann, 2018, Transcriptome engineering with RNA-targeting Type VI-D CRISPR effectors, Cell, 173, 665, 10.1016/j.cell.2018.02.033 Pignatelli, 2019, Engram cell excitability state determines the efficacy of memory retrieval, Neuron, 101, 274, 10.1016/j.neuron.2018.11.029 Bussian, 2018, Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline, Nature, 562, 578, 10.1038/s41586-018-0543-y Bedrosian, 2018, Early life experience drives structural variation of neural genomes in mice, Science, 359, 1395, 10.1126/science.aah3378 Levi, 2018, Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury, J Neurotrauma Guadalajara, 2018, Objective demonstration of improvement of neurogenic bowel dysfunction in a case of spinal cord injury following stem cell therapy, J Surg Case Rep, 2018 Vaquero, 2018, Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline, Cytotherapy, 20, 806, 10.1016/j.jcyt.2018.03.032 Vaquero, 2018, Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia, Cytotherapy, 20, 796, 10.1016/j.jcyt.2018.04.006 Vaquero, 2018, Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury, Neurosci Lett, 670, 14, 10.1016/j.neulet.2018.01.035 Santamaría, 2018, Clinical and neurophysiological changes after targeted intrathecal injections of bone marrow stem cells in a C3 tetraplegic subject, J Neurotrauma, 36, 10.1089/neu.2018.5716 Moviglia, 2018, Local immunomodulation and muscle progenitor cells induce recovery in atrophied muscles in spinal cord injury patients, J Neurorestoratology, 6, 136, 10.26599/JNR.2018.9040011 Al Kandari, 2018, Cell transplantation and clinical reality: Kuwait experience in persons with spinal cord injury, Spinal Cord, 56, 674, 10.1038/s41393-018-0074-2 Liem, 2018, Improved bowel function in patients with spina bifida after bone marrow- derived mononuclear cell transplantation: A report of 2 cases, Am J Case Rep, 19, 1010, 10.12659/AJCR.909801 Sung, 2018, Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability, Am J Transl Res, 10, 2975 Savitz, 2018, A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-Stroke), Circulation, 139, 192, 10.1161/CIRCULATIONAHA.117.030659 Laskowitz, 2018, Allogeneic umbilical cord blood infusion for adults with ischemic stroke: Clinical outcomes from a phase I safety study, Stem Cells Transl Med, 7, 521, 10.1002/sctm.18-0008 van Horne, 2018, Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s diseaseduring deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome, J Neurosurg, 129, 1550, 10.3171/2017.8.JNS163222 Nguyen, 2018, The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy, Health Qual Life Outcomes, 16, 164, 10.1186/s12955-018-0992-x Elena, 2018, Monocyte-derived macrophages for treatment of cerebral palsy: A study of 57 cases, J Neurorestoratology, 6, 41 da Cruz, 2018, Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration, Nat Biotechnol, 36, 328, 10.1038/nbt.4114 Mao, 2018, Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: Design of a multicenter randomized double-blinded placebo-controlled clinical study, J Neurorestoratology, 6, 74, 10.26599/JNR.2018.9040002 Phan, 2018, Phase 1 trial of amnion cell therapy for ischemic stroke, Front Neurol, 9, 198, 10.3389/fneur.2018.00198 Deng, 2018, Intrathecal injection of allogenic bone marrow-derived mesenchymal stromal cells in treatment of patients with severe ischemic stroke: Study protocol for a randomized controlled observer-blinded trial, Transl Stroke Res, 1 Osanai, 2018, Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design, Int J Stroke, 13, 444, 10.1177/1747493017743057 Garitaonandia, 2018, Novel approach to stem cell therapy in Parkinson’s disease, Stem Cells Dev, 27, 951, 10.1089/scd.2018.0001 Loring, 2018, Autologous induced pluripotent stem cell-derived neurons to treat Parkinson’s disease, Stem Cells Dev, 27, 958, 10.1089/scd.2018.0107 Cichoń, 2018, Increase in blood levels of growth factors involved in the neuroplasticity process by using an extremely low frequency electromagnetic field in post-stroke patients, Front Aging Neurosci, 10, 294, 10.3389/fnagi.2018.00294 Angeli, 2018, Recovery of over- ground walking after chronic motor complete spinal cord injury, N Engl J Med, 379, 1244, 10.1056/NEJMoa1803588 Gill, 2018, Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia, Nat Med, 24, 1677, 10.1038/s41591-018-0175-7 Herrity, 2018, Lumbosacral spinal cord epidural stimulation improves voiding function after human spinal cord injury, Sci Rep, 8, 10.1038/s41598-018-26602-2 Terson de Paleville, 2018, Epidural stimulation with locomotor training improves body composition in individuals with cervical or upper thoracic motor complete spinal cord injury: A series of case studies, J Spinal Cord Med, 42, 1 Wagner, 2018, Targeted neurotechnology restores walking in humans with spinal cord injury, Nature, 563, 65, 10.1038/s41586-018-0649-2 Harkema, 2018, Normalization of blood pressure with spinal cord epidural stimulation after severe spinal cord injury, Front Hum Neurosci, 12, 83, 10.3389/fnhum.2018.00083 Aslan, 2018, Epidural spinal cord stimulation of lumbosacral networks modulates arterial blood pressure in individuals with spinal cord injury- induced cardiovascular deficits, Front Physiol, 9, 565, 10.3389/fphys.2018.00565 Poiani, 2018, Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: A randomized controlled trial study protocol, Trials, 19, 17, 10.1186/s13063-017-2414-5 Santos, 2018, Effects of transcranial LED therapy on the cognitive rehabilitation for diffuse axonal injury due to severe acute traumatic brain injury: Study protocol for a randomized controlled trial, Trials, 19, 249, 10.1186/s13063-018-2632-5 da Silva, 2018, Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: Protocol for a randomized, controlled, double-blind, clinical trial, Medicine (Baltimore), 97, 10.1097/MD.0000000000010627 Falci, 2018, Spinal cord injury below- level neuropathic pain relief with dorsal root entry zone microcoagulation performed caudal to level of complete spinal cord transection, J Neurosurg Spine, 28, 612, 10.3171/2017.9.SPINE17373 Huang, 2018, A brief introduction to the Special Issue on clinical treatment of spinal cord injury, J Neurorestoratology, 6, 134, 10.26599/JNR.2018.9040015 Ko, 2018, Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor, Sci Rep, 8, 10.1038/s41598-018-31083-4 Derakhshanrad, 2018, Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: A double-blind randomized controlled clinical trial, J Neurosurg Spine, 1 Derakhshanrad, 2018, Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double- blind randomized controlled clinical trial, J Neurosurg Spine, 29, 97, 10.3171/2017.11.SPINE17769 McDonald, 2018, Placebo- controlled phase 2 trial of drisapersen for Duchenne Muscular Dystrophy, Ann Clin Transl Neurol, 5, 913, 10.1002/acn3.579 Panza, 2018, The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset, Expert Opin Biol Ther, 18, 25, 10.1080/14712598.2018.1389885 Strauss, 2018, Preliminary safety and tolerability of a novel subcutaneous intrathecal catheter system for repeated outpatient dosing of nusinersen to children and adults with spinal muscular atrophy, J Pediatr Orthop, 38, e610, 10.1097/BPO.0000000000001247 Eckstein, 2018, Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunction, Pediatr Hematol Oncol, 1 Kucher, 2018, First-in-man intrathecal application of neurite growth-promoting Anti-Nogo-A antibodies in acute spinal cord injury, Neurorehab Neural Re, 32, 578, 10.1177/1545968318776371 Hubscher, 2018, Improvements in bladder, bowel and sexual outcomes following task-specific locomotor training in human spinal cord injury, PLoS One, 13, 10.1371/journal.pone.0190998 Sandroff, 2018, Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis, BMJ Open, 8, 10.1136/bmjopen-2018-023231 Trento, 2018, Manufacturing mesenchymal stromal cells for the treatment of graft-versus- host disease: A survey among centers affiliated with the European society for blood and marrow transplantation, Biol Blood Marrow Tr, 24, 2365, 10.1016/j.bbmt.2018.07.015 Ao, 2018, Standards for the culture and quality control of umbilical cord mesenchymal stromal cells for neurorestorative clinical application (2017), J Neurorestoratology, 6, 11, 10.2147/JN.S148686 Feng, 2018, Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017), J Neurorestoratology, 6, 115, 10.2147/JN.S147917 Horwitz, 2005, Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement, Cytotherapy, 7, 393, 10.1080/14653240500319234 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Galipeau, 2016, International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials, Cytotherapy, 18, 151, 10.1016/j.jcyt.2015.11.008 Huang, 2018, Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2017), Cell Transplant, 27, 310, 10.1177/0963689717746999 Bikson, 2018, Limited output transcranial electrical stimulation (LOTES-2017): Engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low risk, Brain Stimul, 11, 134, 10.1016/j.brs.2017.10.012